SCHEMBL2919451

SCHEMBL2919451

PC(Cl)(Cl)CCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11435656 0.73
SCHEMBL10962897 0.67
SCHEMBL10688375 0.67
SCHEMBL2565 0.67
SCHEMBL11421568 0.67
SCHEMBL5360418 0.67
SCHEMBL3661688 0.65
SCHEMBL16084768 0.65
SCHEMBL3763612 0.65
SCHEMBL10546124 0.63

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8883833-B2 Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders DECODE GENETICS EHF (IS) 2014-11-11 US disclosed
US-8877816-B2 4-(or 5-) substituted catechol derivatives DECODE GENETICS EHF (IS) 2014-11-04 US disclosed
US-20140301999-A1 BIARYL PDE4 INHIBITORS FOR TREATING INFLAMMATORY, CARDIOVASCULAR AND CNS DISORDERS DECODE GENETICS EHF (IS) 2014-10-09 US disclosed
CN-101918380-B Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and cns disorders DECODE GENETICS EHF 2014-09-24 CN disclosed
US-20140275553-A1 SUBSTITUTED BENZOAZOLE PDE4 INHIBITORS FOR TREATING PULMONARY AND CARDIOVASCULAR DISORDERS DECODE GENETICS EHF (IS) 2014-09-18 US disclosed
US-8791267-B2 Biaryl PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders DECODE GENETICS EHF (IS) 2014-07-29 US disclosed
EP-2674417-A2 Biaryl PDE4 inhibitors for treating inflammation Decode Genetics EHF (IS) 2013-12-18 EP disclosed
CN-103351390-A Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders DECODE GENETICS EHF 2013-10-16 CN disclosed
EP-2628727-A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders Decode Genetics EHF (IS) 2013-08-21 EP disclosed
CN-102026970-B Biaryl PDE4 inhibitors for the treatment of pulmonary and cardiovascular disorders DECODE GENETICS EHF 2013-07-31 CN disclosed
EP-0577065-B1 Silicone surfactants having T-butyl terminated polyether pendants for use in high resilience polyurethane foam OSI SPECIALTIES INC (US) 1997-01-29 EP disclosed
EP-0254890-B1 Polyether silicone copolymers with mixed hydroxy alkoxy capping for stabilizing high solid content, molded, flexible urethane foam OSI SPECIALTIES INC (US) 1995-03-08 EP disclosed
EP-0310929-B1 Polyether silicone copolymers with secondary or tertiary hydroxy terminated for stabilizing high resiliency urethane foam UNION CARBIDE CORP (US) 1994-07-27 EP disclosed
EP-0577065-A1 Silicone surfactants having T-butyl terminated polyether pendants for use in high resilience polyurethane foam OSi Specialties, Inc. (US) 1994-01-05 EP disclosed
US-5198474-A Silicone surfactants having t-butyl terminated polyether pendants for use in high resilience polyurethane foam UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1993-03-30 US disclosed
EP-0310929-A2 Polyether silicone copolymers with secondary or tertiary hydroxy terminated for stabilizing high resiliency urethane foam OSi SPECIALTIES, INC. (US) 1989-04-12 EP disclosed
US-4769174-A NONIONIC SURFACTANTS; BREATHABILITY UNION CARBIDE CORPORATION (US) 1988-09-06 US disclosed
US-4746683-A SURFACTANTS UNION CARBIDE CORPORATION (US) 1988-05-24 US disclosed
EP-0254890-A2 Polyether silicone copolymers with mixed hydroxy alkoxy capping for stabilizing high solid content, molded, flexible urethane foam OSi Specialties, Inc. (US) 1988-02-03 EP disclosed
US-4690955-A HIGH-BREATHABILITY OPEN-CELL FOAMS UNION CARBIDE CORPORATION (US) 1987-09-01 US disclosed